Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain

Authors: Xavier Castellsagué, Teresa Drudis, Maria Paz Cañadas, Anna Goncé, Ramón Ros, José M Pérez, M Jesús Quintana, Jesús Muñoz, Ginesa Albero, Silvia de Sanjosé, F Xavier Bosch

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results.

Methods

To estimate mother-to-child HPV transmission we carried out a prospective cohort study that included 66 HPV-positive and 77 HPV-negative pregnant women and their offspring attending a maternity hospital in Barcelona. To estimate HPV prevalence and genotype distribution in pregnancy we also carried out a related screening survey of cervical HPV-DNA detection among 828 pregnant women. Cervical cells from the mother were collected at pregnancy (mean of 31 weeks) and at the 6-week post-partum visit. Exfoliated cells from the mouth and external genitalia of the infants were collected around birth, at the 6-week post-partum visit, and around 3, 6, 12, and 24 months of age. All samples were tested for HPV using PCR. Associations between potential determinants of HPV infection in pregnant women and of HPV positivity in infants were also explored by logistic regression modelling.

Results

Overall cervical HPV-DNA detection in pregnant women recruited in the HPV screening survey was 6.5% (54/828). Sexual behavior-related variables, previous histories of genital warts or sexually transmitted infections, and presence of cytological abnormalities were statistically significantly and positively associated with HPV DNA detection in pregnant women recruited in the cohort. At 418 infant visits and a mean follow-up time of 14 months, 19.7% of infants born to HPV-positive mothers and 16.9% of those born to HPV-negative mothers tested HPV positive at some point during infants' follow-up. The most frequently detected genotype both in infants and mothers was HPV-16, after excluding untyped HPV infections. We found a strong and statistically significant association between mother's and child's HPV status at the 6-week post-partum visit. Thus, children of mothers' who were HPV-positive at the post-partum visit were about 5 times more likely to test HPV-positive than children of corresponding HPV-negative mothers (p = 0.02).

Conclusion

This study confirms that the risk of vertical transmission of HPV genotypes is relatively low. HPV persistence in infants is a rare event. These data also indicate that vertical transmission may not be the sole source of HPV infections in infants and provides partial evidence for horizontal mother-to-child HPV transmission.
Literature
1.
go back to reference Kjaer SK, Chackerian B, Brule van den AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, et al: High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001, 10: 101-106.PubMed Kjaer SK, Chackerian B, Brule van den AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, et al: High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001, 10: 101-106.PubMed
2.
go back to reference Burchell AN, Winer RL, de Sanjose S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006, 24 (Suppl 3): S52-S61. 10.1016/j.vaccine.2006.05.031.CrossRef Burchell AN, Winer RL, de Sanjose S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006, 24 (Suppl 3): S52-S61. 10.1016/j.vaccine.2006.05.031.CrossRef
3.
go back to reference Cason J, Mant CA: High-risk mucosal human papillomavirus infections during infancy & childhood. J Clin Virol. 2005, 32 (Suppl 1): S52-S58. 10.1016/j.jcv.2004.12.007.CrossRefPubMed Cason J, Mant CA: High-risk mucosal human papillomavirus infections during infancy & childhood. J Clin Virol. 2005, 32 (Suppl 1): S52-S58. 10.1016/j.jcv.2004.12.007.CrossRefPubMed
4.
go back to reference Manos MM, Waldman J, Zhang TY, Greer CE, Eichinger G, Schiffman MH, Wheeler CM: Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis. 1994, 170: 1096-1099.CrossRefPubMed Manos MM, Waldman J, Zhang TY, Greer CE, Eichinger G, Schiffman MH, Wheeler CM: Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis. 1994, 170: 1096-1099.CrossRefPubMed
5.
go back to reference Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, et al: Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002, 68: 417-423. 10.1002/jmv.10220.CrossRefPubMed Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, et al: Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002, 68: 417-423. 10.1002/jmv.10220.CrossRefPubMed
6.
go back to reference Medeiros LR, Ethur AB, Hilgert JB, Zanini RR, Berwanger O, Bozzetti MC, Mylius LC: Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad Saude Publica. 2005, 21: 1006-1015. 10.1590/S0102-311X2005000400003.CrossRefPubMed Medeiros LR, Ethur AB, Hilgert JB, Zanini RR, Berwanger O, Bozzetti MC, Mylius LC: Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad Saude Publica. 2005, 21: 1006-1015. 10.1590/S0102-311X2005000400003.CrossRefPubMed
7.
go back to reference Cason J, Rice P, Best JM: Transmission of cervical cancer-associated human papilloma viruses from mother to child. Intervirology. 1998, 41: 213-218. 10.1159/000024939.CrossRefPubMed Cason J, Rice P, Best JM: Transmission of cervical cancer-associated human papilloma viruses from mother to child. Intervirology. 1998, 41: 213-218. 10.1159/000024939.CrossRefPubMed
8.
go back to reference Syrjanen S, Puranen M: Human papillomavirus infections in children: the potential role of maternal transmission. Crit Rev Oral Biol Med. 2000, 11: 259-274. 10.1177/10454411000110020801.CrossRefPubMed Syrjanen S, Puranen M: Human papillomavirus infections in children: the potential role of maternal transmission. Crit Rev Oral Biol Med. 2000, 11: 259-274. 10.1177/10454411000110020801.CrossRefPubMed
9.
go back to reference Rintala MA, Grenman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjanen SM: Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol. 2005, 43: 376-381. 10.1128/JCM.43.1.376-381.2005.CrossRefPubMedPubMedCentral Rintala MA, Grenman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjanen SM: Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol. 2005, 43: 376-381. 10.1128/JCM.43.1.376-381.2005.CrossRefPubMedPubMedCentral
10.
go back to reference Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, Turek LP: Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis. 2004, 31: 57-62. 10.1097/01.OLQ.0000105327.40288.DB.CrossRefPubMed Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, Turek LP: Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis. 2004, 31: 57-62. 10.1097/01.OLQ.0000105327.40288.DB.CrossRefPubMed
11.
go back to reference Smith EM, Johnson SR, Cripe T, Perlman S, McGuinness G, Jiang D, Cripe L, Turek LP: Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev. 1995, 19: 196-205.PubMed Smith EM, Johnson SR, Cripe T, Perlman S, McGuinness G, Jiang D, Cripe L, Turek LP: Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev. 1995, 19: 196-205.PubMed
12.
go back to reference Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L: Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol. 1991, 100: 479-483.CrossRefPubMed Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L: Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol. 1991, 100: 479-483.CrossRefPubMed
13.
go back to reference Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, Galloway DA: Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol. 1998, 178: 365-373. 10.1016/S0002-9378(98)80027-6.CrossRefPubMed Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, Galloway DA: Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol. 1998, 178: 365-373. 10.1016/S0002-9378(98)80027-6.CrossRefPubMed
14.
go back to reference Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005, 366: 991-998. 10.1016/S0140-6736(05)67069-9.CrossRefPubMed Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005, 366: 991-998. 10.1016/S0140-6736(05)67069-9.CrossRefPubMed
16.
go back to reference Nobbenhuis MA, Helmerhorst TJ, Brule van den AJ, Rozendaal L, Bezemer PD, Voorhorst FJ, Meijer CJ: High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer. 2002, 87: 75-80. 10.1038/sj.bjc.6600367.CrossRefPubMedPubMedCentral Nobbenhuis MA, Helmerhorst TJ, Brule van den AJ, Rozendaal L, Bezemer PD, Voorhorst FJ, Meijer CJ: High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer. 2002, 87: 75-80. 10.1038/sj.bjc.6600367.CrossRefPubMedPubMedCentral
17.
go back to reference Morrison EA, Gammon MD, Goldberg GL, Vermund SH, Burk RD: Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet. 1996, 54: 125-130. 10.1016/0020-7292(96)02694-X.CrossRefPubMed Morrison EA, Gammon MD, Goldberg GL, Vermund SH, Burk RD: Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet. 1996, 54: 125-130. 10.1016/0020-7292(96)02694-X.CrossRefPubMed
18.
go back to reference Fife KH, Katz BP, Brizendine EJ, Brown DR: Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 1999, 180: 1110-1114. 10.1016/S0002-9378(99)70602-2.CrossRefPubMed Fife KH, Katz BP, Brizendine EJ, Brown DR: Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 1999, 180: 1110-1114. 10.1016/S0002-9378(99)70602-2.CrossRefPubMed
19.
go back to reference Sethi S, Muller M, Schneider A, Blettner M, Smith E, Turek L, Wahrendorf J, Gissmann L, Chang-Claude J: Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol. 1998, 178: 360-364. 10.1016/S0002-9378(98)80026-4.CrossRefPubMed Sethi S, Muller M, Schneider A, Blettner M, Smith E, Turek L, Wahrendorf J, Gissmann L, Chang-Claude J: Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol. 1998, 178: 360-364. 10.1016/S0002-9378(98)80026-4.CrossRefPubMed
20.
go back to reference Chan PK, Chang AR, Tam WH, Cheung JL, Cheng AF: Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls. J Med Virol. 2002, 67: 583-588. 10.1002/jmv.10142.CrossRefPubMed Chan PK, Chang AR, Tam WH, Cheung JL, Cheng AF: Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls. J Med Virol. 2002, 67: 583-588. 10.1002/jmv.10142.CrossRefPubMed
21.
go back to reference Chang-Claude J, Schneider A, Smith E, Blettner M, Wahrendorf J, Turek L: Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol. 1996, 60: 355-362. 10.1006/gyno.1996.0055.CrossRefPubMed Chang-Claude J, Schneider A, Smith E, Blettner M, Wahrendorf J, Turek L: Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol. 1996, 60: 355-362. 10.1006/gyno.1996.0055.CrossRefPubMed
Metadata
Title
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
Authors
Xavier Castellsagué
Teresa Drudis
Maria Paz Cañadas
Anna Goncé
Ramón Ros
José M Pérez
M Jesús Quintana
Jesús Muñoz
Ginesa Albero
Silvia de Sanjosé
F Xavier Bosch
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-74

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.